Dubbelman, Mark A. http://orcid.org/0000-0002-5708-4925
,
Jutten, Roos J.
Tomaszewski Farias, Sarah E.
Amariglio, Rebecca E.
Buckley, Rachel F.
Visser, Pieter Jelle
Rentz, Dorene M.
Johnson, Keith A.
Properzi, Michael J.
Schultz, Aaron
Donovan, Nancy
Gatchell, Jennifer R.
Teunissen, Charlotte E.
Van Berckel, Bart N. M.
Van der Flier, Wiesje M.
Sperling, Reisa A.
Papp, Kathryn V.
Scheltens, Philip
Marshall, Gad A.
Sikkes, Sietske A. M.
Funding for this research was provided by:
National Institute on Aging (P01AG036694, 1K23AG053422-01)
Foundation for the National Institutes of Health (U01 AG024904)
Alzheimer Nederland
Article History
Received: 23 July 2020
Accepted: 12 October 2020
First Online: 29 October 2020
Ethics approval and consent to participate
: The studies of which we used data in this study have been approved by their institutions’ respective ethical review boards. All subjects provided written informed consent for the use of their data for research purposes, in accordance with the Declaration of Helsinki.
: Not applicable.
: MAD, RJJ, SETF, REA, RFB, PJV, DMR, KAJ, MJP, AS, ND, JRG, BNMB, and RAS report no disclosures relevant to this manuscript. SAMS is supported by grants from JPND and Zon-MW and has provided consultancy services in the past 2 years for Nutricia and Takeda. All funds were paid to her institution. GAM has received research salary support from Eisai Inc., Eli Lilly and Company, Janssen Alzheimer Immunotherapy, Novartis, and Genentech. Additionally, GAM has served as a consultant for Grifols Shared Services North America, Inc., Eisai Inc., and Pfizer. WMF holds the Pasman chair. CET received grants from the European Commission, the Dutch Research Council (ZonMW), Association of Frontotemporal Dementia/Alzheimer’s Drug Discovery Foundation, The Weston Brain Institute, Alzheimer Nederland. CET has functioned in advisory boards of Roche, received non-financial support in the form of research consumables from ADxNeurosciences and Euroimmun, performed contract research, or received grants from Probiodrug, Biogen, Esai, Toyama, Janssen prevention center, Boehringer, AxonNeurosciences, EIP farma, PeopleBio, and Roche. KVP has served as a paid consultant for Biogen.